Biolase Inc
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosme… Read more
Biolase Inc (BIOLQ) - Total Liabilities
Latest total liabilities as of September 2024: $32.47 Million USD
Based on the latest financial reports, Biolase Inc (BIOLQ) has total liabilities worth $32.47 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Biolase Inc - Total Liabilities Trend (2020–2023)
This chart illustrates how Biolase Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Biolase Inc Competitors by Total Liabilities
The table below lists competitors of Biolase Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
African Discovery Group Inc
PINK:AFDG
|
USA | $798.61K |
|
Hempstract Inc
PINK:HPST
|
USA | $1.72 Million |
|
LiveChain Inc
PINK:LICH
|
USA | $112.40K |
|
PipeHawk plc
LSE:PIP
|
UK | GBX8.03 Million |
|
Us1 Critical Minerals Limited
AU:USC
|
Australia | AU$168.75K |
|
Sproutly Canada Inc
STU:38G
|
Germany | €9.77 Million |
Liability Composition Analysis (2020–2023)
This chart breaks down Biolase Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -6.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biolase Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biolase Inc (2020–2023)
The table below shows the annual total liabilities of Biolase Inc from 2020 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $35.35 Million | +6.16% |
| 2022-12-31 | $33.30 Million | +10.71% |
| 2021-12-31 | $30.08 Million | -2.97% |
| 2020-12-31 | $31.00 Million | -- |